Search Results - "Higa, Motoyuki"

Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia by KATSUTA, Narimasa, OHNUMA, Tohru, HANZAWA, Ryo, HIGASHIYAMA, Ryoko, SHIBATA, Nobuto, ARAI, Heii, MAESHIMA, Hitoshi, TAKEBAYASHI, Yuto, HIGA, Motoyuki, TAKEDA, Mayu, NAKAMURA, Toru, NISHIMON, Shohei, SANNOHE, Takahiro, HOTTA, Yuri

“…Altered peripheral carbonyl stress markers, high levels of serum pentosidine, which accumulates following carbonyl stress, and low levels of pyridoxal (vitamin…”
Get full text

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia by Takeda, Mayu, Ohnuma, Tohru, Takeuchi, Masayoshi, Katsuta, Narimasa, Maeshima, Hitoshi, Takebayashi, Yuto, Higa, Motoyuki, Nakamura, Toru, Nishimon, Shohei, Sannohe, Takahiro, Hotta, Yuri, Hanzawa, Ryo, Higashiyama, Ryoko, Shibata, Nobuto, Gohda, Tomohito, Suzuki, Yusuke, Yamagishi, Sho-ichi, Tomino, Yasuhiko, Arai, Heii

“…•Advanced glycation end product (AGE) is a carbonyl stress marker of schizophrenia.•Glycer-AGE and receptors for AGE (sRAGE) were involved in neurotoxic…”
Get full text

Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS) by Hotta, Yuri, Ohnuma, Tohru, Hanzawa, Ryo, Shibata, Nobuto, Maeshima, Hitoshi, Baba, Hajime, Hatano, Tokiko, Takebayashi, Yuto, Kitazawa, Maiko, Higa, Motoyuki, Suzuki, Toshihito, Arai, Heii

“…Treating the 20–30% of patients with schizophrenia whose symptoms are resistant to antipsychotic treatment, a condition known as treatment-resistant…”
Get full text

No genetic association between SLC7A10 and Japanese patients with schizophrenia by Takebayashi, Yuto, Ohnuma, Tohru, Hanzawa, Ryo, Shibata, Nobuto, Maeshima, Hitoshi, Baba, Hajime, Hatano, Tokiko, Hotta, Yuri, Kitazawa, Maiko, Higa, Motoyuki, Arai, Heii

“…Disrupted glutamatergic neurotransmission may be a pathophysiological feature in the brains from patients with schizophrenia, and glutamatergic amino acids…”
Get full text

No Correlation between Plasma NMDA-Related Glutamatergic Amino Acid Levels and Cognitive Function in Medicated Patients with Schizophrenia by Ohnuma, Tohru, Sakai, Yoshie, Maeshima, Hitoshi, Higa, Motoyuki, Hanzawa, Ryo, Kitazawa, Maiko, Hotta, Yuri, Katsuta, Narimasa, Takebayashi, Yuto, Shibata, Nobuto, Arai, Heii

“…Objective: Disrupted glutamatergic neurotransmission and cognitive functions are key components in the pathophysiology of schizophrenia. Changes in levels of…”
Get full text

NO CORRELATION BETWEEN PLASMA NMDA-RELATED GLUTAMATERGIC AMINO ACID LEVELS AND COGNITIVE FUNCTION IN MEDICATED PATIENTS WITH SCHIZOPHRENIA by OHNUMA, Tohru, SAKAI, Yoshie, ARAI, Heii, MAESHIMA, Hitoshi, HIGA, Motoyuki, HANZAWA, Ryo, KITAZAWA, Maiko, HOTTA, Yuri, KATSUTA, Narimasa, TAKEBAYASHI, Yuto, SHIBATA, Nobuto

Get full text